BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 30150481)

  • 1. Alanine Scanning Mutagenesis of the MEDI4893 (Suvratoxumab) Epitope Reduces Alpha Toxin Lytic Activity
    Tkaczyk C; Semenova E; Shi YY; Rosenthal K; Oganesyan V; Warrener P; Stover CK; Sellman BR
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Action for an All-in-One Monoclonal Antibody Against Staphylococcus aureus Infection.
    Hou WT; Shen CR; Peng J; Jiang LW; Guo SY; Qiu XR; Zhang Y; Shen H; Jiang YY; An MM
    J Infect Dis; 2023 Dec; 228(12):1789-1799. PubMed ID: 37335928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization and preliminary X-ray diffraction analysis of the complex between a human anti-alpha toxin antibody fragment and alpha toxin.
    Oganesyan V; Barnes A; Tkaczyk C; Ferguson A; Wu H; Dall'Acqua WF
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Mar; 69(Pt 3):302-5. PubMed ID: 23519809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.
    Thomsen IP; Sapparapu G; James DBA; Cassat JE; Nagarsheth M; Kose N; Putnam N; Boguslawski KM; Jones LS; Wood JB; Creech CB; Torres VJ; Crowe JE
    J Infect Dis; 2017 Apr; 215(7):1124-1131. PubMed ID: 28186295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxin-neutralizing Abs are associated with improved T cell function following recovery from Staphylococcus aureus infection.
    Kleinhenz M; Li Z; Chidella U; Picard W; Wolfe A; Popelka J; Alexander R; Montgomery CP
    JCI Insight; 2024 Jan; 9(4):. PubMed ID: 38236641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-directed mutagenesis to assess the binding capacity of class s protein of Staphylococcus aureus leucotoxins to the surface of polymorphonuclear cells.
    Moussa LB; Werner S; Coraiola M; Colin DA; Keller D; Sanni A; Serra MD; Monteil H; Prévost G
    J Biomed Biotechnol; 2006; 2006(2):80101. PubMed ID: 16883055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study of the Penetration of a Monoclonal Antibody Combination (ASN100) Targeting
    Magyarics Z; Leslie F; Bartko J; Rouha H; Luperchio S; Schörgenhofer C; Schwameis M; Derhaschnig U; Lagler H; Stiebellehner L; Firbas C; Weber S; Campanaro E; Jilma B; Nagy E; Stevens C
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial.
    François B; Mercier E; Gonzalez C; Asehnoune K; Nseir S; Fiancette M; Desachy A; Plantefève G; Meziani F; de Lame PA; Laterre PF;
    Intensive Care Med; 2018 Nov; 44(11):1787-1796. PubMed ID: 30343314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of suvratoxumab for prevention of Staphylococcus aureus ventilator-associated pneumonia (SAATELLITE): a multicentre, randomised, double-blind, placebo-controlled, parallel-group, phase 2 pilot trial.
    François B; Jafri HS; Chastre J; Sánchez-García M; Eggimann P; Dequin PF; Huberlant V; Viña Soria L; Boulain T; Bretonnière C; Pugin J; Trenado J; Hernandez Padilla AC; Ali O; Shoemaker K; Ren P; Coenjaerts FE; Ruzin A; Barraud O; Timbermont L; Lammens C; Pierre V; Wu Y; Vignaud J; Colbert S; Bellamy T; Esser MT; Dubovsky F; Bonten MJ; Goossens H; Laterre PF;
    Lancet Infect Dis; 2021 Sep; 21(9):1313-1323. PubMed ID: 33894131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus α-toxin: small pore, large consequences.
    von Hoven G; Qin Q; Neukirch C; Husmann M; Hellmann N
    Biol Chem; 2019 Sep; 400(10):1261-1276. PubMed ID: 30951494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines and Monoclonal Antibodies as Alternative Strategies to Antibiotics to Fight Antimicrobial Resistance.
    La Guidara C; Adamo R; Sala C; Micoli F
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico-Ex Vitro Iteration Strategy for Affinity Maturation of Anti-Ricin Peptides and the SPR Biosensing Application.
    Yang Z; Wang C; Liu J; Xiao L; Guo L; Xie J
    Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in Monoclonal Antibody-Based Approaches in the Management of Bacterial Sepsis.
    Kharga K; Kumar L; Patel SKS
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Targets for Antibody-Based Anti-Biofilm Therapy in Infective Endocarditis.
    Han J; Poma A
    Polymers (Basel); 2022 Aug; 14(15):. PubMed ID: 35956712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic landscapes on
    Kailasan S; Kant R; Noonan-Shueh M; Kanipakala T; Liao G; Shulenin S; Leung DW; Alm RA; Adhikari RP; Amarasinghe GK; Gross ML; Aman MJ
    MAbs; 2022; 14(1):2083467. PubMed ID: 35730685
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Clegg J; Soldaini E; McLoughlin RM; Rittenhouse S; Bagnoli F; Phogat S
    Front Immunol; 2021; 12():705360. PubMed ID: 34305945
    [No Abstract]   [Full Text] [Related]  

  • 17. Antivirulence Strategies for the Treatment of
    Ford CA; Hurford IM; Cassat JE
    Front Microbiol; 2020; 11():632706. PubMed ID: 33519793
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Blümel E; Munir Ahmad S; Nastasi C; Willerslev-Olsen A; Gluud M; Fredholm S; Hu T; Surewaard BGJ; Lindahl LM; Fogh H; Koralov SB; Rahbek Gjerdrum LM; Clark RA; Iversen L; Krejsgaard T; Bonefeld CM; Geisler C; Becker JC; Woetmann A; Andersen MH; Buus TB; Ødum N
    Oncoimmunology; 2020; 9(1):1751561. PubMed ID: 32363124
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens.
    Zurawski DV; McLendon MK
    Antibiotics (Basel); 2020 Apr; 9(4):. PubMed ID: 32244733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Application of Epitopes in EtMIC1 of
    Zhao N; Ming S; Lu Y; Wang F; Li H; Zhang X; Zhao X
    Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.